PATENT CLAIM ANALYSIS

Application Number: 16215340
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "389000"]

Abstract:
Methods for treating triple negative breast cancer with an androgen receptor inhibitor are provided, as well as methods for screening for the likelihood of the effectiveness of such treatment.

Claim (Index 25):
A method of treating triple negative breast cancer in a subject in raced of such treatment comprising:\n (a) providing a biological sample from the subject; (b) assaying the biological sample to determine whether the biological sample is classified as a basal-like subtype or another subtype, wherein the Basal Centroid classifier score of breast cancer cells is determined for the breast cancer cells of the subject from the expression by said cells of the set of intrinsic genes listed in Table 1 and wherein the breast cancer cells of the subject are characterized by a Basal Centroid classifier score of less than or equal to 0.9; and (c) if the biological sample is classified as the other than a basal-like subtype, administering a breast cancer treatment to the subject comprising an androgen receptor inhibitor, thereby treating the breast cancer in the subject.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 98.0
- Lexical Diversity: 1.19231
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14962864', '15075373', '13421367', '14759889', '12995450']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6997585923622581
- 35 USC 102 Novelty (BERT): 0.706178179217701
- Combined Prediction Score: 0.7004005510478024
- Mean Citation Score: 429.173646
- Max Citation Score: 886.7025
- Similarity Product: 719.5722502112387

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test